Inhibikase Therapeutics I...

NASDAQ: IKT · Real-Time Price · USD
2.24
0.00 (0.00%)
At close: May 02, 2025, 3:59 PM
2.21
-1.34%
After-hours: May 02, 2025, 04:29 PM EDT

Inhibikase Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
-27.52M -19.03M -18.05M -14.79M -2.85M -5.72M -2.15M -436.07K -628.74K
26.27K 177.4K 6.72K n/a n/a n/a n/a n/a n/a
8.14M 500.15K 458.15K 1.53M 573.7K 1.44M 642.23K 300.66K 310.09K
-66.85K 699.28K 39.53K -2.33M -217.57K 1.17M 256.73K 159.41K 98.91K
n/a 31.54K 67K 721.63K 1.61M 2.32M 709.27K 534.62K 95.71K
n/a n/a n/a n/a n/a n/a n/a n/a n/a
204.93K 234.76K 171.18K -1.76M -464.64K 1.63M 1.52M -32.76K 193.36K
-19.15M -18.09M -17.35M -14.3M -1.13M -338.29K 714.99K -126.39K -29.57K
n/a -14.24K -243.25K n/a n/a n/a n/a n/a n/a
n/a n/a 243.25K n/a n/a n/a n/a n/a n/a
-60.46M -29.43M -20.73M n/a n/a n/a n/a n/a n/a
23.45M 41.1M 4.96M n/a n/a n/a n/a n/a n/a
n/a n/a -243.25K n/a n/a n/a 87.1K n/a n/a
-37M 11.66M -16.01M n/a n/a n/a 87.1K n/a n/a
n/a n/a -248.91K -42.53K 272.8K -22.81K -26.31K n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a 848.00 n/a n/a -1.59M 131.02K -23.77K
103.48M 8.41M -204.77K 41.09M 15.06M -22.81K -439.19K 131.02K -23.77K
47.33M 1.98M -33.56M 26.8M 13.94M -361.1K 362.89K 4.63K -53.34K
-19.15M -18.1M -17.59M -14.3M -1.13M -338.29K 714.99K -126.39K -29.57K